ORMP
Oramed Pharmaceuticals Inc
Price:  
2.46 
USD
Volume:  
175,533.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ORMP WACC - Weighted Average Cost of Capital

The WACC of Oramed Pharmaceuticals Inc (ORMP) is 6.5%.

The Cost of Equity of Oramed Pharmaceuticals Inc (ORMP) is 7.20%.
The Cost of Debt of Oramed Pharmaceuticals Inc (ORMP) is 7.00%.

Range Selected
Cost of equity 5.50% - 8.90% 7.20%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 5.4% - 7.6% 6.5%
WACC

ORMP WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.35 0.73
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.50% 8.90%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.53 0.53
Cost of debt 7.00% 7.00%
After-tax WACC 5.4% 7.6%
Selected WACC 6.5%